A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors
RATIONALE: Compounds acting on delta opioid receptors (DOR) modulate anxiety-like behaviors, yet the site of action underlying this effect is unknown. DOR mRNA and protein are expressed in the central nucleus of the amygdala, a region that plays an important role in processing fear, stress, and anxiety. We hypothesized that this brain region may contribute to the modulation of anxiety by DOR drugs.
OBJECTIVE: The present study investigated the role of DOR in the central amygdala in anxiety-like behaviors.
METHODS: The selective DOR agonist [D-Pen 2,5]-enkephalin (DPDPE) or antagonist naltrindole was bilaterally microinjected into the central nucleus of the amygdala of adult male Sprague Dawley rats and anxiety-like behaviors were assessed using the elevated plus maze. The effects of DOR agonists on heightened anxiety produced by stress were also investigated.
RESULTS: Rats injected with DPDPE into the central nucleus of the amygdala demonstrated less anxiety-like behavior, as evidenced by significantly greater number of open-arm entries and time spent in the open arms than controls. Naltrindole administered alone did not affect the duration or number of entries onto the open arms; however, naltrindole pre-treatment blocked the anxiolytic effects produced by DPDPE. Systemic administration of the selective DOR agonist, SNC80, or microinjection of DPDPE into the central amygdala prior to a swim stress blocked the anxiogenic effect produced by the swim stress.
CONCLUSIONS: These findings provide direct evidence that activation of DOR in the central amygdala reduces anxiety-like behavior and suggest that DOR in this area are important for regulating anxious states.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2010 |
---|---|
Erschienen: |
2010 |
Enthalten in: |
Zur Gesamtaufnahme - volume:212 |
---|---|
Enthalten in: |
Psychopharmacology - 212(2010), 4 vom: 17. Dez., Seite 585-95 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Randall-Thompson, Jovita F [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.02.2011 Date Revised 20.10.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00213-010-1980-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM200504363 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM200504363 | ||
003 | DE-627 | ||
005 | 20231223220711.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2010 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00213-010-1980-y |2 doi | |
028 | 5 | 2 | |a pubmed24n0668.xml |
035 | |a (DE-627)NLM200504363 | ||
035 | |a (NLM)20730419 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Randall-Thompson, Jovita F |e verfasserin |4 aut | |
245 | 1 | 2 | |a A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors |
264 | 1 | |c 2010 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.02.2011 | ||
500 | |a Date Revised 20.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a RATIONALE: Compounds acting on delta opioid receptors (DOR) modulate anxiety-like behaviors, yet the site of action underlying this effect is unknown. DOR mRNA and protein are expressed in the central nucleus of the amygdala, a region that plays an important role in processing fear, stress, and anxiety. We hypothesized that this brain region may contribute to the modulation of anxiety by DOR drugs | ||
520 | |a OBJECTIVE: The present study investigated the role of DOR in the central amygdala in anxiety-like behaviors | ||
520 | |a METHODS: The selective DOR agonist [D-Pen 2,5]-enkephalin (DPDPE) or antagonist naltrindole was bilaterally microinjected into the central nucleus of the amygdala of adult male Sprague Dawley rats and anxiety-like behaviors were assessed using the elevated plus maze. The effects of DOR agonists on heightened anxiety produced by stress were also investigated | ||
520 | |a RESULTS: Rats injected with DPDPE into the central nucleus of the amygdala demonstrated less anxiety-like behavior, as evidenced by significantly greater number of open-arm entries and time spent in the open arms than controls. Naltrindole administered alone did not affect the duration or number of entries onto the open arms; however, naltrindole pre-treatment blocked the anxiolytic effects produced by DPDPE. Systemic administration of the selective DOR agonist, SNC80, or microinjection of DPDPE into the central amygdala prior to a swim stress blocked the anxiogenic effect produced by the swim stress | ||
520 | |a CONCLUSIONS: These findings provide direct evidence that activation of DOR in the central amygdala reduces anxiety-like behavior and suggest that DOR in this area are important for regulating anxious states | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 7 | |a Analgesics, Opioid |2 NLM | |
650 | 7 | |a Narcotic Antagonists |2 NLM | |
650 | 7 | |a Receptors, Opioid, delta |2 NLM | |
650 | 7 | |a Naltrexone |2 NLM | |
650 | 7 | |a 5S6W795CQM |2 NLM | |
650 | 7 | |a Enkephalin, D-Penicillamine (2,5)- |2 NLM | |
650 | 7 | |a 88373-73-3 |2 NLM | |
650 | 7 | |a naltrindole |2 NLM | |
650 | 7 | |a G167Z38QA4 |2 NLM | |
700 | 1 | |a Pescatore, Karen A |e verfasserin |4 aut | |
700 | 1 | |a Unterwald, Ellen M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Psychopharmacology |d 1977 |g 212(2010), 4 vom: 17. Dez., Seite 585-95 |w (DE-627)NLM00009434X |x 1432-2072 |7 nnns |
773 | 1 | 8 | |g volume:212 |g year:2010 |g number:4 |g day:17 |g month:12 |g pages:585-95 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00213-010-1980-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 212 |j 2010 |e 4 |b 17 |c 12 |h 585-95 |